No Data
Express News | Shenzhen Mindray Bio-Medical Electronics Says Board Elected Li Xiting as Chairman
Orient Securities: Empowering the pharmaceuticals and biotechnology sector's global expansion; seize the opportunity to strategically position in innovative drug contract manufacturing.
Domestic centralized procurement and healthcare reform policies are gradually becoming more moderate, while international operations, after years of cultivation, have already gained momentum and continue to accelerate overseas expansion.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Mindray Medical: First Quarter Report for 2026
Mindray Medical: Understand Mindray\'s First-Quarter 2026 Report at a Glance
Express News | Shenzhen Mindray Bio-Medical Electronics Says Q1 Net Profit Down 11.4% Y/Y
IATB : The previous level has already been broken, and now $169.52 is the lowest point in a year.![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)